---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

{% include base_path %}

This page features full-length papers where I am one of the authors. For conference abstracts see [Abstracts](/abstracts/)

You can also find my papers on <u><a href="{{author.googlescholar}}">my Google Scholar profile</a>.</u>

<sup>#</sup> Denotes equal contributions 

# FIRST / CO-FIRST AUTHOR

1. Arthur Chow<sup>#</sup>, **Hoyin Chu**<sup>#</sup>, <em>et al.</em> (2025) Sequence and structural determinants of efficacious de novo chimeric antigen receptors. **bioRxiv**. DOI: https://doi.org/10.64898/2025.12.12.694033

1. Mohammed Al-Jumaan<sup>#</sup>, **Hoyin Chu**<sup>#</sup>, <em>et al.</em> (2023) Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients. **Genome Medicine**. DOI: https://doi.org/10.1186/s13073-023-01220-4

1. Abdullah Al-Sulaiman<sup>#</sup>, **Hoyin Chu**<sup>#</sup>, <em>et al.</em> (2023) Profiling of pharmacogenomic variants in CYP2D6 and DPYD in indigenous Arab breast cancer patients. **Pharmacogenomics**. DOI: https://doi.org/10.2217/pgs-2023-0029

1. **Hoyin Chu**, <em>et al.</em> (2023) Using Association Rules to Understand the Risk of Adverse Pregnancy Outcomes in a Diverse Population, **Pacific Symposium on Biocomputing**. DOI: https://doi.org/10.1142/9789811270611_0020

1. Kymberleigh A. Pagel<sup>#</sup>, **Hoyin Chu**<sup>#</sup>, <em>et al.</em> (2022) The influence of genetic predisposition and physical activity on risk of Gestational Diabetes Mellitus in the nuMoM2b cohort. **JAMA Network Open**. DOI: https://doi.org/10.1001/jamanetworkopen.2022.29158


# CO-AUTHOR

1. Maria Caterina Rotiroti, Aidan M Tousley, **Hoyin Chu**, <em>et al.</em> (2025) Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapy. **Nature Cancer**. DOI: https://doi.org/10.1038/s43018-025-01056-4

1. Mark B Leick, ..., **Hoyin Chu**, <em>et al.</em> (2025) Genomic correlates of clinical CAR-T cell activity. **medRxiv**. DOI: https://doi.org/10.1101/2025.10.08.25337584
 
1. Alexandre Pellan Cheng, ..., **Hoyin Chu**, <em>et al.</em> (2025) Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling. **Nature Methods**. DOI: https://doi.org/10.1038/s41592-025-02648-9

1. Romualdo Barroso-Sousa, ..., **Hoyin Chu**, <em>et al.</em> (2025) Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS). **Nature Communications**. DOI: https://doi.org/10.1038/s41467-025-59695-1

1. Seung Hun Han, Sabrina Y. Camp, **Hoyin Chu**, <em>et al.</em> (2024) Integrative Analysis of Germline Rare Variants in Clear and Nonâ€“clear Cell Renal Cell Carcinoma. **European Urology Open Science**. DOI: https://doi.org/10.1016/j.euros.2024.02.006.

1. The Critical Assessment of Genome Interpretation Consortium, including **Hoyin Chu**. (2024) CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods. **Genome Biology**. DOI: https://doi.org/10.1186/s13059-023-03113-6

1. Riaz Gillani, Sabrina Y. Camp, Seunghun Han, Jill K. Jones, **Hoyin Chu**, <em>et al.</em> (2022) Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. **The American Journal of Human Genetics**. DOI: https://doi.org/10.1016/j.ajhg.2022.04.007

<br/>


---
<a href="#top">Back to top</a>
<br/>
Last update: 2024-06-08

<!-- {% if author.googlescholar %}
  You can also find my articles on <u><a href="{{author.googlescholar}}">my Google Scholar profile</a>.</u>
{% endif %} -->
<!-- 
{% include base_path %}

{% for post in site.publications reversed %}
  {% include archive-single.html %}
{% endfor %} -->
